Apremilast (APR), an anti-psoriatic agent, easily forms isostructural cocrystals and solvates with aromatic entities, often disobeying at the same time Kitaigorodsky’s rule as to the saturation of possible hydrogen bonding sites. In this paper the reasons standing behind this peculiar behavior are investigated, employing a joint experimental and theoretical approach. This includes the design of cocrystals with coformers having high propensity towards the formation of both aromatic – aromatic and hydrogen bonding interactions, determination of their structure, using solid state NMR spectroscopy and X-Ray crystallography, as well as calculations of stabilization energies of formation of the obtained cocrystals, followed by crystal structure ...
Despite significant ongoing experimental and computational efforts, factors involved in the choice b...
The selection of the crystalline phases in a form of molecular cocrystals has become scientific chal...
Solubility enhancement of poorly-soluble active pharmaceutical ingredients (APIs) remains a scientif...
(<i>S</i>)-<i>N</i>-{2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1...
International audiencePolymorphism commonly exists in the preparation of cocrystals and has attracte...
In the last years, the design and synthesis of co-crystals containing active pharmaceutical ingredi...
Cocrystals have recently gained attention as attractive alternate solid forms for drug development. ...
The primary aim of pharmaceutical materials engineering is the successful formulation and process de...
The primary aim of pharmaceutical materials engineering is the successful formulation and process de...
The primary aim of pharmaceutical materials engineering is the successful formulation and process de...
We present a combined experimental and theoretical study of the structures and bench stability of ha...
The selection of the crystalline phases in a form of molecular cocrystals has become scientific chal...
The primary aim of pharmaceutical materials engineering is the successful formulation and process de...
Abstract The selection of the crystalline phases in a form of molecular cocrystals has become scient...
Abstract The selection of the crystalline phases in a form of molecular cocrystals has become scient...
Despite significant ongoing experimental and computational efforts, factors involved in the choice b...
The selection of the crystalline phases in a form of molecular cocrystals has become scientific chal...
Solubility enhancement of poorly-soluble active pharmaceutical ingredients (APIs) remains a scientif...
(<i>S</i>)-<i>N</i>-{2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1...
International audiencePolymorphism commonly exists in the preparation of cocrystals and has attracte...
In the last years, the design and synthesis of co-crystals containing active pharmaceutical ingredi...
Cocrystals have recently gained attention as attractive alternate solid forms for drug development. ...
The primary aim of pharmaceutical materials engineering is the successful formulation and process de...
The primary aim of pharmaceutical materials engineering is the successful formulation and process de...
The primary aim of pharmaceutical materials engineering is the successful formulation and process de...
We present a combined experimental and theoretical study of the structures and bench stability of ha...
The selection of the crystalline phases in a form of molecular cocrystals has become scientific chal...
The primary aim of pharmaceutical materials engineering is the successful formulation and process de...
Abstract The selection of the crystalline phases in a form of molecular cocrystals has become scient...
Abstract The selection of the crystalline phases in a form of molecular cocrystals has become scient...
Despite significant ongoing experimental and computational efforts, factors involved in the choice b...
The selection of the crystalline phases in a form of molecular cocrystals has become scientific chal...
Solubility enhancement of poorly-soluble active pharmaceutical ingredients (APIs) remains a scientif...